Pfizer stock: buy or sell
Updated on:
Jul 29th, 2021
2
Pfizer stock brief
- After marking new all-time highs on Wednesday, Pfizer closed at $43.45 skyrocketing a 3.21%
- It's been 5 consecutive sessions in green for Pfizer, gaining a 4.77%
- On Tuesday, Pfizer posted its Q2 earnings report
- The price is currently above the upper Bollinger band, which often indicates a near-term correction
- On July 20 broke out above its latest top at $40.69
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Should I buy Pfizer stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $PFE stock a buy?
In the current situation of Pfizer there is not any eligible buy setup. This doesn't mean $PFE will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Pfizer stock?
"To sell or not to sell", if you are holding Pfizer stock?. Like when we have to buy shares, deciding when is the best time to sell is not a capricious decision, and we must adhere our own trading strategy. When selling, as well as buying, detailed strategies are very easy to follow and are only applicable for selling shares in your porfolio, not for shorting Pfizer stock
A golden rule is that you should not hold a trade that results in greater losses than those expected upon the buy. The moment to sell your stock must always be determined by the stop-loss (automatic or manual)
Is it time to sell Pfizer stock?
In the current situation of Pfizer there is not any eligible sell setup, so Pfizer stock holders with operations in green can keep their positions
Pfizer ratings
We don't have any rating posted in the last 30 days for Pfizer
Pfizer stock analysis
Since last February, Pfizer has been printing an uptrend that so far marked a gorgeous 31.55%. The price shows higher highs and lows, and along the way gave very few buy points for those who wanted to trade in. Latest low was in early June, when price bounced at $38.48. On July 20, Pfizer broke out above its last top ($40.69) giving a good buying opportunity
$PFE at new All-time Highs
On Wednesday, Pfizer hit all-time highs (ATH) again at $43.74
SMAs overview
Supports and resistances
Price is at all-time highs and there are not upper resistances.
The current support levels are:
Bollinger bands
When the price moves out of the band (above the upper line or below the lower line) it indicates that the stock is currently having a very strong trend and therefore can correct the trend to the average. In this case, the price is beyond the upper band, meaning a near-term adjustment (at least) until it is under the band
Relative strength index
Broke through the overbought line Wednesday, marking a value of 82.4. Breaking through above the level of 70 is not a sell signal, as stocks can be above the level of 70 for many, many weeks and continue to rise
Pfizer stock price history
Pfizer went public on Jun 1st, 1972 at $0.00 per share1. Since then, PFE stock surged by -, with an average of 0.00% per year. An investment of thousand dollars on the IPO would have a value of $inf nowadays.
1: Adjusted price after possible price splits or reverse-splits
Price target for Pfizer stock
How much a stock will be priced tomorrow or next week is quite unpredictable. However, many stock price forecasts are posted every day by banks, financial institutions and independent analysts.
The following table shows the price target released by analysts in the last month. Again, these forecasts are not direct recommendations for small traders and must not be trusted blindly.
We don't have any target price published in the previous 4 weeks for Pfizer.
Earnings and financials
On Tuesday, Pfizer ($PFE) had the quarterly investors event and presented the report.
Same quarter last year, reported EPS was $0.78, so current EPS is -100.00%. Turnover exploded a 21.23% on an annualized basis in the , from $120.3B to $145.8B last quarter.Pfizer ($PFE) is presenting quarterly earnings report next October.
Pfizer performance
| Company | 1m | 3m | 6m |
|---|---|---|---|
| Pfizer ($PFE) | 11.00% | 12.50% | 22.10% |
Important note:
The opinions published in this post are personal and not recommendations for you to buy or sell stocks. The author of this paper does not have any knowledge of the specific conditions of the reader, his or her finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are expressed for general educational reasons onlyPfizer summary
| Wednesday, July 28th, 2021 | |
|---|---|
| Open | $42.35 |
| Close | $43.45 |
| Day range | $42.25 - $43.74 |
| Previous close | $42.1 |
| Session gain | 3.21% |
| Average true range | $0.71 |
| 50d mov avg | $39.71 |
| 100d mov avg | $38.39 |
| 200d mov avg | $36.99 |
| Earnings date | October 25th, 2021 |